Eisai's David Martin named chairman of NPC's board

WASHINGTON — The National Pharmaceutical Council on Friday announced that David Martin, SVP market access and commercial services for Eisai, has been named chairman of NPC's board of directors for 2014-15. Martin has served on the board since 2011 and held the positions of vice chair and treasurer. 

 

"We've benefited from Dave's extensive experience and thoughtful approach toward advancing NPC's research and communications during his tenure on the board," said NPC president Dan Leonard. "We look forward to his leadership in helping us address health policy challenges, such as ensuring patient access to medicines, especially in today's changing delivery and reimbursement environment."

 

Martin's career includes positions with Johnson & Johnson, Pharmacia (which is now part of Pfizer) and Wolters Kluwer, where he progressed through roles within sales, sales management, marketing management and general management. He has been with Eisai for more than five years and currently serves as the company's senior leader for its B-to-B interactions with Eisai's major segments and customers.

 

"I am honored to be elected chairman of NPC's board of directors," Martin said. "Through its many research and education initiatives, NPC continues to play a vital role in bringing critical health policy issues to the forefront, all in an effort to support an environment in which medical innovation flourishes. I look forward to working with my fellow board members in the year ahead to further NPC's mission."